MEA Viscosupplementation Market - Industry Trends and Forecast to 2029
Description
MEA Viscosupplementation Market - Industry Trends and Forecast to 2029
Middle East & Africa viscosupplementation market is projected to register a substantial CAGR of 6.2% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2022 to 2029.
Market Segmentation
Middle East & Africa Viscosupplementation Market, By Source (animal origin and non-animal origin), Age Group (geriatric and adults), Injection (single injection, three injections, and five injections), Molecular Weight (intermediate molecular weight, low molecular weight, and high molecular weight), End User (hospital, orthopedic clinics, ambulatory care centers, and others), Distribution Channel (direct tender and retail sales), Country(Saudi Arabia, UAE, Egypt, Israel, South Africa, Kuwait, and rest of the Middle East and Africa) Industry Trends and Forecast to 2029.
Some of the major factors contributing to the growth of the Middle East & Africa viscosupplementation market are:
Rising geriatric population
Increasing risk of osteoporosis and osteoarthritis
Market Segmentation
Middle East & Africa viscosupplementation market is categorized into six notable segments, which are the source, age group, molecular weight, injection, end user, and distribution channel.
On the basis of source, the Middle East & Africa viscosupplementation market is segmented into animal origin and non-animal origin
On the basis of molecular weight, the Middle East & Africa viscosupplementation market is segmented into intermediate molecular weight, low molecular weight, and high molecular weight
On the basis of injection, the Middle East & Africa viscosupplementation market is segmented into single injections, three injections, and five injections
On the basis of age group, the Middle East & Africa viscosupplementation market is segmented into geriatric and adults
On the basis of end-user, the Middle East & Africa viscosupplementation market is segmented into hospitals, orthopedic clinics, ambulatory care centers, and others
On the basis of distribution channel, the Middle East & Africa viscosupplementation market is segmented into direct tender and retail sales
Market Players
The key market players operating in the Middle East & Africa viscosupplementation market are listed below:
Anika Therapeutics, Inc.
TRB CHEMEDICA SA
Teva Pharmaceutical Industries Ltd.
Lifecore (a subsidiary of Landec Corporation)
VIRCHOW BIOTECH
Zuventus HealthCare Ltd. (a subsidiary of Emcure Pharmaceuticals)
Company Profiles
Anika Therapeutics, Inc.
TRB CHEMEDICA SA
Teva Pharmaceutical Industries Ltd.
Lifecore (a subsidiary of Landec Corporation)
VIRCHOW BIOTECH
Zuventus HealthCare Ltd. (a subsidiary of Emcure Pharmaceuticals)
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Middle East & Africa viscosupplementation market is projected to register a substantial CAGR of 6.2% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2022 to 2029.
Market Segmentation
Middle East & Africa Viscosupplementation Market, By Source (animal origin and non-animal origin), Age Group (geriatric and adults), Injection (single injection, three injections, and five injections), Molecular Weight (intermediate molecular weight, low molecular weight, and high molecular weight), End User (hospital, orthopedic clinics, ambulatory care centers, and others), Distribution Channel (direct tender and retail sales), Country(Saudi Arabia, UAE, Egypt, Israel, South Africa, Kuwait, and rest of the Middle East and Africa) Industry Trends and Forecast to 2029.
Some of the major factors contributing to the growth of the Middle East & Africa viscosupplementation market are:
Rising geriatric population
Increasing risk of osteoporosis and osteoarthritis
Market Segmentation
Middle East & Africa viscosupplementation market is categorized into six notable segments, which are the source, age group, molecular weight, injection, end user, and distribution channel.
On the basis of source, the Middle East & Africa viscosupplementation market is segmented into animal origin and non-animal origin
On the basis of molecular weight, the Middle East & Africa viscosupplementation market is segmented into intermediate molecular weight, low molecular weight, and high molecular weight
On the basis of injection, the Middle East & Africa viscosupplementation market is segmented into single injections, three injections, and five injections
On the basis of age group, the Middle East & Africa viscosupplementation market is segmented into geriatric and adults
On the basis of end-user, the Middle East & Africa viscosupplementation market is segmented into hospitals, orthopedic clinics, ambulatory care centers, and others
On the basis of distribution channel, the Middle East & Africa viscosupplementation market is segmented into direct tender and retail sales
Market Players
The key market players operating in the Middle East & Africa viscosupplementation market are listed below:
Anika Therapeutics, Inc.
TRB CHEMEDICA SA
Teva Pharmaceutical Industries Ltd.
Lifecore (a subsidiary of Landec Corporation)
VIRCHOW BIOTECH
Zuventus HealthCare Ltd. (a subsidiary of Emcure Pharmaceuticals)
Company Profiles
Anika Therapeutics, Inc.
TRB CHEMEDICA SA
Teva Pharmaceutical Industries Ltd.
Lifecore (a subsidiary of Landec Corporation)
VIRCHOW BIOTECH
Zuventus HealthCare Ltd. (a subsidiary of Emcure Pharmaceuticals)
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Table of Contents
224 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of Middle East & Africa Viscosupplementation Market
- 1.4 Currency And Pricing
- 1.5 Limitations
- 1.6 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Dbmr Tripod Data Validation Model
- 2.5 Primary Interviews With Key Opinion Leaders
- 2.6 Multivariate Modelling
- 2.7 Market Application Coverage Grid
- 2.8 Source Lifeline Curve
- 2.9 Dbmr Market Position Grid
- 2.10 Vendor Share Analysis
- 2.11 Secondary Sources
- 2.12 Assumptions
- 3 Executive Summary
- 4 Premium Insight
- 4.1 Pestel
- 4.2 Porter's Five Forces Model
- 5 Epidemiology
- 6 Industrial Insights
- 7 Pipeline Analysis For Middle East & Africa Viscosupplementation Market
- 8 Middle East & Africa Viscosupplementation Market: Regulations
- 9 Market Overview
- 9.1 Drivers
- 9.1.1 Rising Geriatric Population
- 9.1.2 Increasing Risk Of Osteoporosis And Osteoarthritis
- 9.1.3 Technological Advancement In Viscosupplementation
- 9.1.4 Low Production Cost Of Viscosupplementation Products
- 9.2 Restraints
- 9.2.1 Lack Of Technical Expertise
- 9.2.2 Product Recall Procedures
- 9.2.3 Limited Applications Of Viscosupplementation
- 9.3 Opportunities
- 9.3.1 Safety And Effectiveness Of Intra-articular Hyaluronic Acid (Iaha)
- 9.3.2 Rising Healthcare Infrastructure
- 9.3.3 Increase In Demand For Minimally Invasive Procedures
- 9.3.4 Increasing Number Of Joint Replacements And Sports Accident
- 9.4 Challenges
- 9.4.1 Stringent Government Policies For The Use Of Viscosupplementation
- 9.4.2 Side-effects Of Viscosupplementation
- 10 Middle East & Africa Viscosupplementation Market, By Source
- 10.1 Overview
- 10.2 Non-animal Origin
- 10.2.1 Orthovisc
- 10.2.2 Euflexxa
- 10.2.3 Monovisc
- 10.2.4 Durolane
- 10.2.5 Gel-one
- 10.2.6 Supartz
- 10.2.7 Gelsyn-3
- 10.2.8 Cingal
- 10.2.9 Sulplasyn
- 10.2.10 Viscoseal
- 10.2.11 Osteonil
- 10.2.12 Others
- 10.3 Animal Origin
- 10.3.1 Hylan G-f 20
- 10.3.2 Synvic One
- 10.3.3 Synvic
- 10.3.4 Others
- 10.3.5 Hyaluronans
- 10.3.6 Hyalgan
- 10.3.7 Others
- 11 Middle East & Africa Viscosupplementation Market, By Molecular Weight
- 11.1 Overview
- 11.2 Intermediate Molecular Weight
- 11.2.1 Orthovisc
- 11.2.2 Euflexxa
- 11.2.3 Monovisc
- 11.2.4 Durolane
- 11.2.5 Viscoseal
- 11.2.6 Osteonil
- 11.2.7 Others
- 11.3 Low Molecular Weight
- 11.3.1 Hylagan
- 11.3.2 Supartz
- 11.3.3 Gelsyn-3
- 11.3.4 Cingal
- 11.3.5 Sulplasyn
- 11.3.6 Others
- 11.4 High Molecular Weight
- 11.4.1 Synvic One
- 11.4.2 Synvic
- 11.4.3 Others
- 12 Middle East & Africa Viscosupplementation Market, By Injection
- 12.1 Overview
- 12.2 Single Injection
- 12.3 Three Injection
- 12.4 Five Injection
- 13 Middle East & Africa Viscosupplementation Market, By Age Group
- 13.1 Overview
- 13.2 Adults
- 13.3 Geriatric
- 14 Middle East & Africa Viscosupplementation Market, By End User
- 14.1 Overview
- 14.2 Hospitals
- 14.3 Orthopedic Clinics
- 14.4 Ambulatory Care Centers
- 14.5 Others
- 15 Middle East & Africa Viscosupplementation Market, By Distribution Channel
- 15.1 Overview
- 15.2 Retail Sales
- 15.3 Direct Tender
- 16 Middle East & Africa Viscosupplementation Market, By Region
- 16.1 Middle East And Africa
- 16.1.1 South Africa
- 16.1.2 Egypt
- 16.1.3 Saudi Arabia
- 16.1.4 U.A.E
- 16.1.5 Israel
- 16.1.6 Kuwait
- 16.1.7 Rest Of Middle East And Africa
- 17 Middle East & Africa Viscosupplementation Market: Company Landscape
- 17.1 Company Share Analysis: Middle East & Africa
- 18 Swot Analysis
- 19 Company Profile
- 19.1 Johnson & Johnson Services, Inc.
- 19.1.1 Company Snapshot
- 19.1.2 Revenue Analysis
- 19.1.3 Company Share Analysis
- 19.1.4 Product Portfolio
- 19.1.5 Recent Developments
- 19.2 Bioventus
- 19.2.1 Company Snapshot
- 19.2.2 Revenue Analysis
- 19.2.3 Company Share Analysis
- 19.2.4 Product Portfolio
- 19.2.5 Recent Developments
- 19.3 Ferring B.V.
- 19.3.1 Company Snapshot
- 19.3.2 Company Share Analysis
- 19.3.3 Product Portfolio
- 19.3.4 Recent Development
- 19.4 Sanofi-aventis U.S. Llc
- 19.4.1 Company Snapshot
- 19.4.2 Revenue Analysis
- 19.4.3 Company Share Analysis
- 19.4.4 Product Portfolio
- 19.4.5 Recent Developments
- 19.5 Zimmer Biomet
- 19.5.1 Company Snapshot
- 19.5.2 Revenue Analysis
- 19.5.3 Company Share Analysis
- 19.5.4 Product Portfolio
- 19.5.5 Recent Developments
- 19.6 Seikagaku Corporation
- 19.6.1 Company Snapshot
- 19.6.2 Revenue Analysis
- 19.6.3 Product Portfolio
- 19.6.4 Recent Developments
- 19.7 Anika Therapeutics, Inc.
- 19.7.1 Company Snapshot
- 19.7.2 Revenue Analysis
- 19.7.3 Product Portfolio
- 19.7.4 Recent Developments
- 19.8 Fidia Farmaceutici S.P.A
- 19.8.1 Company Snapshot
- 19.8.2 Revenue Analysis
- 19.8.3 Product Portfolio
- 19.8.4 Recent Development
- 19.9 Aptissen
- 19.9.1 Company Snapshot
- 19.9.2 Product Portfolio
- 19.9.3 Recent Development
- 19.10 Ibsa Institut Biochimique Sa
- 19.10.1 Company Snapshot
- 19.10.2 Product Portfolio
- 19.10.3 Recent Development
- 19.11 Lg Chem.
- 19.11.1 Company Snapshot
- 19.11.2 Revenue Analysis
- 19.11.3 Product Portfolio
- 19.11.4 Recent Developments
- 19.12 Lifecore (A Subsidiary Of Landec Corporation)
- 19.12.1 Company Snapshot
- 19.12.2 Revenue Analysis
- 19.12.3 Product Portfolio
- 19.12.4 Recent Developments
- 19.13 Orthogenrx, Inc. (A Subsidiary Of Avns)
- 19.13.1 Company Snapshot
- 19.13.2 Revenue Analysis
- 19.13.3 Product Portfolio
- 19.13.4 Recent Developments
- 19.14 Ortobrand International
- 19.14.1 Company Snapshot
- 19.14.2 Product Portfolio
- 19.14.3 Recent Development
- 19.15 Teva Pharmaceutical Industries Ltd.
- 19.15.1 Company Snapshot
- 19.15.2 Revenue Analysis
- 19.15.3 Product Portfolio
- 19.15.4 Recent Developments
- 19.16 Trb Chemedica Sa
- 19.16.1 Company Snapshot
- 19.16.2 Product Portfolio
- 19.16.3 Recent Developments
- 19.17 Viatris Inc.
- 19.17.1 Company Snapshot
- 19.17.2 Revenue Analysis
- 19.17.3 Product Portfolio
- 19.17.4 Recent Developments
- 19.18 Virchow Biotech
- 19.18.1 Company Snapshot
- 19.18.2 Product Portfolio
- 19.18.3 Recent Development
- 19.19 Zuventus Healthcare Ltd. (A Subsidiary Of Emcure Pharmaceuticals)
- 19.19.1 Company Snapshot
- 19.19.2 Revenue Analysis
- 19.19.3 Product Portfolio
- 19.19.4 Recent Development
- 20 Questionnaire
- 21 Related Reports
- List Of Tables
- Table 1 Middle East & Africa Viscosupplementation Market, By Source, 2020-2029 (Usd Million)
- Table 2 Middle East & Africa Non-animal In Viscosupplementation Market, By Region, 2020-2029 (Usd Million)
- Table 3 Middle East & Africa Non-animal Origin In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 4 Middle East & Africa Non-animal Origin In Viscosupplementation Market, By Brand, 2020-2029 (Units)
- Table 5 Middle East & Africa Animal In Viscosupplementation Market, By Region, 2020-2029 (Usd Million)
- Table 6 Middle East & Africa Animal Origin In Viscosupplementation Market, By Type, 2020-2029 (Usd Million)
- Table 7 Middle East & Africa Hylan G-f 20 In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 8 Middle East & Africa Hylan G-f 20 In Viscosupplementation Market, By Brand, 2020-2029 (Units)
- Table 9 Middle East & Africa Hyaluronans In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 10 Middle East & Africa Hyaluronans In Viscosupplementation Market, By Brand, 2020-2029 (Units)
- Table 11 Middle East & Africa Viscosupplementation Market, By Molecular Weight, 2020-2029 (Usd Million)
- Table 12 Middle East & Africa Intermediate Molecular Weight In Viscosupplementation Market, By Region, 2020-2029 (Usd Million)
- Table 13 Middle East & Africa Intermediate Molecular Weight In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 14 Middle East & Africa Low Molecular Weight In Viscosupplementation Market, By Region, 2020-2029 (Usd Million)
- Table 15 Middle East & Africa Low Molecular Weight In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 16 Middle East & Africa High Molecular Weight In Viscosupplementation Market, By Region, 2020-2029 (Usd Million)
- Table 17 Middle East & Africa High Molecular Weight In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 18 Middle East & Africa Viscosupplementation Market, By Injection, 2020-2029 (Usd Million)
- Table 19 Middle East & Africa Single Injection In Viscosupplementation Market, By Region, 2020-2029 (Usd Million)
- Table 20 Middle East & Africa Three Injection In Viscosupplementation Market, By Region, 2020-2029 (Usd Million)
- Table 21 Middle East & Africa Five Injection In Viscosupplementation Market, By Region, 2020-2029 (Usd Million)
- Table 22 Middle East & Africa Viscosupplementation Market, By Age Group, 2020-2029 (Usd Million)
- Table 23 Middle East & Africa Adult In Viscosupplementation Market, By Region, 2020-2029 (Usd Million)
- Table 24 Middle East & Africa Geriatric In Viscosupplementation Market, By Region, 2020-2029 (Usd Million)
- Table 25 Middle East & Africa Viscosupplementation Market, By End User, 2020-2029 (Usd Million)
- Table 26 Middle East & Africa Hospitals In Viscosupplementation Market, By Region, 2020-2029 (Usd Million)
- Table 27 Middle East & Africa Orthopeadic Clinics In Viscosupplementation Market, By Region, 2020-2029 (Usd Million)
- Table 28 Middle East & Africa Ambulatory Care Centers In Viscosupplementation Market, By Region, 2020-2029 (Usd Million)
- Table 29 Middle East & Africa Others In Viscosupplementation Market, By Region, 2020-2029 (Usd Million)
- Table 30 Middle East & Africa Viscosupplementation Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 31 Middle East & Africa Retail Sales In Viscosupplementation Market, By Region, 2020-2029 (Usd Million)
- Table 32 Middle East & Africa Direct Tender In Viscosupplementation Market, By Region, 2020-2029 (Usd Million)
- Table 33 Middle East And Africa Viscosupplementation Market, By Country, 2020-2029 (Usd Million)
- Table 34 Middle East And Africa Viscosupplementation Market, By Source, 2020-2029 (Usd Million)
- Table 35 Middle East And Africa Non-animal Origin In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 36 Middle East And Africa Non-animal Origin In Viscosupplementation Market, By Brand, 2020-2029 (Units)
- Table 37 Middle East And Africa Animal Origin In Viscosupplementation Market, By Type, 2020-2029 (Usd Million)
- Table 38 Middle East And Africa Hylan G-f 20 In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 39 Middle East And Africa Hylan G-f 20 In Viscosupplementation Market, By Brand, 2020-2029 (Units)
- Table 40 Middle East And Africa Hyaluronans In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 41 Middle East And Africa Hyaluronans In Viscosupplementation Market, By Brand, 2020-2029 (Units)
- Table 42 Middle East And Africa Viscosupplementation Market, By Molecular Weight, 2020-2029 (Usd Million)
- Table 43 Middle East And Africa Intermediate Molecular Weight In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 44 Middle East And Africa Low Molecular Weight In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 45 Middle East And Africa High Molecular Weight In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 46 Middle East And Africa Viscosupplementation Market, By Injection, 2020-2029 (Usd Million)
- Table 47 Middle East And Africa Viscosupplementation Market, By Age Group, 2020-2029 (Usd Million)
- Table 48 Middle East And Africa Viscosupplementation Market, By End User, 2020-2029 (Usd Million)
- Table 49 Middle East And Africa Viscosupplementation Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 50 South Africa Viscosupplementation Market, By Source, 2020-2029 (Usd Million)
- Table 51 South Africa Non-animal Origin In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 52 South Africa Non-animal Origin In Viscosupplementation Market, By Brand, 2020-2029 (Units)
- Table 53 South Africa Non-animal Origin In Viscosupplementation Market, By Brand, 2020-2029 (Asp,Usd)
- Table 54 South Africa Animal Origin In Viscosupplementation Market, By Type, 2020-2029 (Usd Million)
- Table 55 South Africa Hylan G-f 20 In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 56 South Africa Hylan G-f 20 In Viscosupplementation Market, By Brand, 2020-2029 (Units)
- Table 57 South Africa Hylan G-f 20 In Viscosupplementation Market, By Brand, 2020-2029 (Asp, Usd)
- Table 58 South Africa Viscosupplementation Market, By Molecular Weight, 2020-2029 (Usd Million)
- Table 59 South Africa Intermediate Molecular Weight In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 60 South Africa Low Molecular Weight In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 61 South Africa High Molecular Weight In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 62 South Africa Viscosupplementation Market, By Injection, 2020-2029 (Usd Million)
- Table 63 South Africa Viscosupplementation Market, By Age Group, 2020-2029 (Usd Million)
- Table 64 South Africa Viscosupplementation Market, By End User, 2020-2029 (Usd Million)
- Table 65 South Africa Viscosupplementation Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 66 Egypt Viscosupplementation Market, By Source, 2020-2029 (Usd Million)
- Table 67 Egypt Non-animal Origin In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 68 Egypt Non-animal Origin In Viscosupplementation Market, By Brand, 2020-2029 (Units)
- Table 69 Egypt Non-animal Origin In Viscosupplementation Market, By Brand, 2020-2029 (Asp,Usd)
- Table 70 Egypt Animal Origin In Viscosupplementation Market, By Type, 2020-2029 (Usd Million)
- Table 71 Egypt Hylan G-f 20 In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 72 Egypt Hylan G-f 20 In Viscosupplementation Market, By Brand, 2020-2029 (Units)
- Table 73 Egypt Hylan G-f 20 In Viscosupplementation Market, By Brand, 2020-2029 (Asp, Usd)
- Table 74 Egypt Hyaluronans In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 75 Egypt Hyaluronans In Viscosupplementation Market, By Brand, 2020-2029 (Units)
- Table 76 Egypt Hyaluronans In Viscosupplementation Market, By Brand, 2020-2029 (Asp, Usd)
- Table 77 Egypt Viscosupplementation Market, By Molecular Weight, 2020-2029 (Usd Million)
- Table 78 Egypt Intermediate Molecular Weight In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 79 Egypt Low Molecular Weight In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 80 Egypt High Molecular Weight In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 81 Egypt Viscosupplementation Market, By Injection, 2020-2029 (Usd Million)
- Table 82 Egypt Viscosupplementation Market, By Age Group, 2020-2029 (Usd Million)
- Table 83 Egypt Viscosupplementation Market, By End User, 2020-2029 (Usd Million)
- Table 84 Egypt Viscosupplementation Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 85 Saudi Arabia Viscosupplementation Market, By Source, 2020-2029 (Usd Million)
- Table 86 Saudi Arabia Non-animal Origin In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 87 Saudi Arabia Non-animal Origin In Viscosupplementation Market, By Brand, 2020-2029 (Units)
- Table 88 Saudi Arabia Non-animal Origin In Viscosupplementation Market, By Brand, 2020-2029 (Asp,Usd)
- Table 89 Saudi Arabia Animal Origin In Viscosupplementation Market, By Type, 2020-2029 (Usd Million)
- Table 90 Saudi Arabia Hylan G-f 20 In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 91 Saudi Arabia Hylan G-f 20 In Viscosupplementation Market, By Brand, 2020-2029 (Units)
- Table 92 Saudi Arabia Hylan G-f 20 In Viscosupplementation Market, By Brand, 2020-2029 (Asp, Usd)
- Table 93 Saudi Arabia Hyaluronans In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 94 Saudi Arabia Hyaluronans In Viscosupplementation Market, By Brand, 2020-2029 (Units)
- Table 95 Saudi Arabia Hyaluronans In Viscosupplementation Market, By Brand, 2020-2029 (Asp, Usd)
- Table 96 Saudi Arabia Viscosupplementation Market, By Molecular Weight, 2020-2029 (Usd Million)
- Table 97 Saudi Arabia Intermediate Molecular Weight In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 98 Saudi Arabia Low Molecular Weight In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 99 Saudi Arabia High Molecular Weight In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 100 Saudi Arabia Viscosupplementation Market, By Injection, 2020-2029 (Usd Million)
- Table 101 Saudi Arabia Viscosupplementation Market, By Age Group, 2020-2029 (Usd Million)
- Table 102 Saudi Arabia Viscosupplementation Market, By End User, 2020-2029 (Usd Million)
- Table 103 Saudi Arabia Viscosupplementation Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 104 U.A.E Viscosupplementation Market, By Source, 2020-2029 (Usd Million)
- Table 105 U.A.E Non-animal Origin In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 106 U.A.E Non-animal Origin In Viscosupplementation Market, By Brand, 2020-2029 (Units)
- Table 107 U.A.E Non-animal Origin In Viscosupplementation Market, By Brand, 2020-2029 (Asp,Usd)
- Table 108 U.A.E Animal Origin In Viscosupplementation Market, By Type, 2020-2029 (Usd Million)
- Table 109 U.A.E Hylan G-f 20 In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 110 U.A.E Hylan G-f 20 In Viscosupplementation Market, By Brand, 2020-2029 (Units)
- Table 111 U.A.E Hylan G-f 20 In Viscosupplementation Market, By Brand, 2020-2029 (Asp, Usd)
- Table 112 U.A.E Hyaluronans In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 113 U.A.E Hyaluronans In Viscosupplementation Market, By Brand, 2020-2029 (Units)
- Table 114 U.A.E Hyaluronans In Viscosupplementation Market, By Brand, 2020-2029 (Asp, Usd)
- Table 115 U.A.E Viscosupplementation Market, By Molecular Weight, 2020-2029 (Usd Million)
- Table 116 U.A.E Intermediate Molecular Weight In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 117 U.A.E Low Molecular Weight In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 118 U.A.E High Molecular Weight In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 119 U.A.E Viscosupplementation Market, By Injection, 2020-2029 (Usd Million)
- Table 120 U.A.E Viscosupplementation Market, By Age Group, 2020-2029 (Usd Million)
- Table 121 U.A.E Viscosupplementation Market, By End User, 2020-2029 (Usd Million)
- Table 122 U.A.E Viscosupplementation Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 123 Israel Viscosupplementation Market, By Source, 2020-2029 (Usd Million)
- Table 124 Israel Non-animal Origin In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 125 Israel Non-animal Origin In Viscosupplementation Market, By Brand, 2020-2029 (Units)
- Table 126 Israel Non-animal Origin In Viscosupplementation Market, By Brand, 2020-2029 (Asp,Usd)
- Table 127 Israel Animal Origin In Viscosupplementation Market, By Type, 2020-2029 (Usd Million)
- Table 128 Israel Hylan G-f 20 In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 129 Israel Hylan G-f 20 In Viscosupplementation Market, By Brand, 2020-2029 (Units)
- Table 130 Israel Hylan G-f 20 In Viscosupplementation Market, By Brand, 2020-2029 (Asp, Usd)
- Table 131 Israel Viscosupplementation Market, By Molecular Weight, 2020-2029 (Usd Million)
- Table 132 Israel Intermediate Molecular Weight In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 133 Israel Low Molecular Weight In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 134 Israel High Molecular Weight In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 135 Israel Viscosupplementation Market, By Injection, 2020-2029 (Usd Million)
- Table 136 Israel Viscosupplementation Market, By Age Group, 2020-2029 (Usd Million)
- Table 137 Israel Viscosupplementation Market, By End User, 2020-2029 (Usd Million)
- Table 138 Israel Viscosupplementation Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 139 Kuwait Viscosupplementation Market, By Source, 2020-2029 (Usd Million)
- Table 140 Kuwait Non-animal Origin In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 141 Kuwait Non-animal Origin In Viscosupplementation Market, By Brand, 2020-2029 (Units)
- Table 142 Kuwait Non-animal Origin In Viscosupplementation Market, By Brand, 2020-2029 (Asp,Usd)
- Table 143 Kuwait Animal Origin In Viscosupplementation Market, By Type, 2020-2029 (Usd Million)
- Table 144 Kuwait Hylan G-f 20 In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 145 Kuwait Hylan G-f 20 In Viscosupplementation Market, By Brand, 2020-2029 (Units)
- Table 146 Kuwait Hylan G-f 20 In Viscosupplementation Market, By Brand, 2020-2029 (Asp, Usd)
- Table 147 Kuwait Hyaluronans In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 148 Kuwait Hyaluronans In Viscosupplementation Market, By Brand, 2020-2029 (Units)
- Table 149 Kuwait Hyaluronans In Viscosupplementation Market, By Brand, 2020-2029 (Asp, Usd)
- Table 150 Kuwait Viscosupplementation Market, By Molecular Weight, 2020-2029 (Usd Million)
- Table 151 Kuwait Intermediate Molecular Weight In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 152 Kuwait Low Molecular Weight In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 153 Kuwait High Molecular Weight In Viscosupplementation Market, By Brand, 2020-2029 (Usd Million)
- Table 154 Kuwait Viscosupplementation Market, By Injection, 2020-2029 (Usd Million)
- Table 155 Kuwait Viscosupplementation Market, By Age Group, 2020-2029 (Usd Million)
- Table 156 Kuwait Viscosupplementation Market, By End User, 2020-2029 (Usd Million)
- Table 157 Kuwait Viscosupplementation Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 158 Rest Of Middle East And Africa Viscosupplementation Market, By Source, 2020-2029 (Usd Million)
- List Of Figures
- Figure 1 Middle East & Africa Viscosupplementation Market: Segmentation
- Figure 2 Middle East & Africa Viscosupplementation Market: Data Triangulation
- Figure 3 Middle East & Africa Viscosupplementation Market: Droc Analysis
- Figure 4 Middle East & Africa Viscosupplementation Market: Regional Vs Country Market Analysis
- Figure 5 Middle East & Africa Viscosupplementation Market: Company Research Analysis
- Figure 6 Middle East & Africa Viscosupplementation Market: Interview Demographics
- Figure 7 Middle East & Africa Viscosupplementation Market: Market Application Coverage Grid
- Figure 8 Middle East & Africa Viscosupplementation Market: Dbmr Market Position Grid
- Figure 9 Middle East & Africa Viscosupplementation Market: Vendor Share Analysis
- Figure 10 Middle East & Africa Viscosupplementation Market: Segmentation
- Figure 11 North America Is Anticipated To Dominate The Middle East & Africa Viscosupplementation Market, And Asia-pacific Is Estimated To Be Growing With The Highest Cagr In The Forecast Period Of 2022 To 2029
- Figure 12 The Increasing Demand For Non-surgical Treatments For Osteoarthritis And Advancements In The Development Of Hyaluronic Acid-based Therapies Is Expected To Drive The Middle East & Africa Viscosupplementation Market In The Forecast Period Of 2022 To 2029
- Figure 13 Non-animal Origin Is Expected To Account For The Largest Share Of The Middle East & Africa Viscosupplementation Market In 2022 & 2029
- Figure 14 Drivers, Restraints, Opportunities, And Challenges Of The Middle East & Africa Viscosupplementation Market
- Figure 15 Middle East & Africa Viscosupplementation Market: By Source, 2021
- Figure 16 Middle East & Africa Viscosupplementation Market: By Source, 2022-2029 (Usd Million)
- Figure 17 Middle East & Africa Viscosupplementation Market: By Source, Cagr (2022-2029)
- Figure 18 Middle East & Africa Viscosupplementation Market: By Source, Lifeline Curve
- Figure 19 Middle East & Africa Viscosupplementation Market: By Molecular Weight, 2021
- Figure 20 Middle East & Africa Viscosupplementation Market: By Molecular Weight, 2022-2029 (Usd Million)
- Figure 21 Middle East & Africa Viscosupplementation Market: By Molecular Weight, Cagr (2022-2029)
- Figure 22 Middle East & Africa Viscosupplementation Market: By Molecular Weight, Lifeline Curve
- Figure 23 Middle East & Africa Viscosupplementation Market: By Injection, 2021
- Figure 24 Middle East & Africa Viscosupplementation Market: By Injection, 2022-2029 (Usd Million)
- Figure 25 Middle East & Africa Viscosupplementation Market: By Injection, Cagr (2022-2029)
- Figure 26 Middle East & Africa Viscosupplementation Market: By Injection, Lifeline Curve
- Figure 27 Middle East & Africa Viscosupplementation Market: By Age Group, 2021
- Figure 28 Middle East & Africa Viscosupplementation Market: By Age Group, 2022-2029 (Usd Million)
- Figure 29 Middle East & Africa Viscosupplementation Market: By Age Group, Cagr (2022-2029)
- Figure 30 Middle East & Africa Viscosupplementation Market: By Age Group, Lifeline Curve
- Figure 31 Middle East & Africa Viscosupplementation Market: By End User, 2021
- Figure 32 Middle East & Africa Viscosupplementation Market: By End User, 2022-2029 (Usd Million)
- Figure 33 Middle East & Africa Viscosupplementation Market: By End User, Cagr (2022-2029)
- Figure 34 Middle East & Africa Viscosupplementation Market: By End User, Lifeline Curve
- Figure 35 Middle East & Africa Viscosupplementation Market: By Distribution Channel, 2021
- Figure 36 Middle East & Africa Viscosupplementation Market: By Distribution Channel, 2022-2029 (Usd Million)
- Figure 37 Middle East & Africa Viscosupplementation Market: By Distribution Channel, Cagr (2022-2029)
- Figure 38 Middle East & Africa Viscosupplementation Market: By Distribution Channel, Lifeline Curve
- Figure 39 Middle East And Africa Viscosupplementation Market: Snapshot (2021)
- Figure 40 Middle East And Africa Viscosupplementation Market: By Country (2021)
- Figure 41 Middle East And Africa Viscosupplementation Market: By Country (2022 & 2029)
- Figure 42 Middle East And Africa Viscosupplementation Market: By Country (2021 & 2029)
- Figure 43 Middle East And Africa Viscosupplementation Market: By Source (2022-2029)
- Figure 44 Middle East & Africa Viscosupplementation Market: Company Share 2021 (%)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
